Skip to main content
Kaya Limited logo

Kaya Limited — Investor Relations & Filings

Ticker · KAYA ISIN · INE587G01015 LEI · 335800GE9WJ2KDECK480 BSE.NS Human health and social work activities
Open in API
Filings indexed 628 across all filing types
Latest filing 2023-05-31 Capital/Financing Update
Country IN India
Listing BSE.NS KAYA

About Kaya Limited

https://www.kaya.in

Kaya Limited provides specialized skin, hair, and body care solutions through a network of clinics and a portfolio of dermatological products. The organization offers advanced aesthetic treatments, including laser hair reduction, anti-aging procedures, acne management, and pigmentation correction. Utilizing medical-grade technology and a team of dermatologists, the company delivers customized care plans tailored to individual dermatological needs. Its product range includes specialized cleansers, moisturizers, and serums designed to support and enhance clinical outcomes. The company focuses on clinical efficacy and safety, providing comprehensive aesthetic wellness solutions for individuals seeking professional dermatological care and maintenance.

Recent filings

Filing Released Lang Actions
Acquisition
Capital/Financing Update Classification · 95% confidence The document is an official disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the acquisition of a 100% equity stake in a subsidiary company, Kaya Beauty Clinic LLC SP, by Kaya Middle East FZE, a step-down subsidiary of Kaya Limited. The document provides detailed information about the acquisition, including the nature of the transaction, shareholding details, and background of the acquired entity. There is no financial report, earnings data, or management discussion of financial results. The content is an update on a corporate event related to capital structure and ownership changes. Therefore, this fits best under Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing fallback. Confidence is high due to clear regulatory reference and detailed acquisition disclosure.
2023-05-31 English
Annual Secretarial Compliance Report
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Report for the Financial Year ended March 31, 2023' and is addressed to stock exchanges. It is a detailed compliance report prepared by a company secretary firm, reviewing statutory compliance and corporate governance adherence for the full financial year ending March 31, 2023. The content focuses on compliance with SEBI regulations, secretarial standards, board processes, and other governance-related matters. It does not contain financial statements or financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). It is not an announcement or a brief notification but a full compliance report. This type of document aligns with the category of Regulatory Filings (RNS) as it is a statutory compliance report submitted to regulators and stock exchanges, not a financial report or management report. Therefore, the best classification is Regulatory Filings (RNS).
2023-05-30 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains detailed tables of related party transactions for the half year ended March 31, 2023, including values approved by the audit committee, types of transactions, and financial indebtedness details. The document is addressed to stock exchanges and is a regulatory compliance disclosure rather than a full financial report or earnings release. It is not an announcement of a report but the actual disclosure document itself. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document that does not fit into other specific categories like Annual Report or Interim Report.
2023-05-25 English
Investor Presentation
Interim / Quarterly Report Classification · 95% confidence The document is a performance update from Kaya Limited dated May 25, 2023, providing detailed financial and operational highlights for the quarter ended March 31, 2023 (Q4 FY23). It includes growth metrics, strategic pillars, expansion details, innovation initiatives, awards, and key performance indicators. The document is approximately 15,000 characters long and contains substantive financial data and analysis for the quarter, not just a brief announcement or a link to a report. It is not a full annual report but a quarterly performance update with financial results and business insights. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q4 2023
2023-05-25 English
Press Release
Earnings Release Classification · 95% confidence The document is a media release dated May 24, 2023, announcing the financial results for the fourth quarter ended March 31, 2023. It includes detailed financial performance data such as revenue growth, profit/loss after tax, and segment-wise business performance for both standalone and consolidated results. The document is over 6,000 characters and contains substantive financial data and analysis for a quarterly period. It is not a full annual report but a quarterly earnings announcement with key highlights and financial metrics. Therefore, it fits the definition of an Earnings Release (ER). Q4 2023
2023-05-24 English
Updates
Regulatory Filings Classification · 95% confidence The document is an official communication from Kaya Limited to stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It announces that the Board of Directors has approved seeking shareholder approval via postal ballot for certain corporate actions, including making loans, guarantees, and sale or disposal of assets exceeding 20% of the assets held by a material subsidiary. The document details the proposed business reorganization in the Middle East region, involving restructuring ownership and operations of clinics through subsidiaries and joint ventures. There are no financial statements or detailed financial performance data included. The document is an announcement of corporate actions and future shareholder voting, not a full report or financial disclosure. It fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement under SEBI regulations about corporate governance and shareholder approval processes, without substantive financial data or report content.
2023-05-24 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.